The implementation of PET in non-small-cell lung cancer in the Netherlands [6]

Clinical Oncology

Volumn 18, Issue 2, 2006, Pages 156-157

  van Tinteren, H ^a   Hoesktra, O S ^a   Smit, E F ^a   Boers, M ^a  

^a Integraal Kankercentrum Amsterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CENTER; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CIGARETTE SMOKING; CLINICAL PRACTICE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FOLLOW UP; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; NETHERLANDS; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REIMBURSEMENT; THORACOTOMY; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; COST-BENEFIT ANALYSIS; HUMANS; LUNG NEOPLASMS; NETHERLANDS; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; RANDOMIZED CONTROLLED TRIALS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 31644450522     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2005.11.023     Document Type: Letter

References (5)

1. P. Price G. Laking How should we introduce clinical PET in the UK? The oncologists need to have a view Clin Oncol 16 2004 172-175
2. K. Flynn E. Adams Technology assessment: Positron emission tomography Original report http://www.va.gov/vatap/pubs/pet1.htm 1996 (last accessed 9 November 2005)
3. G.J. Herder P. Verboom E.F. Smit et al. Practice, efficacy and cost of staging suspected non-small cell lung cancer: A retrospective study in two Dutch hospitals Thorax 57 2002 11-14
4. H. van Tinteren O.S. Hoekstra E.F. Smit et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: The PLUS multicentre randomised trial Lancet 359 2002 1388-1393
5. P. Verboom H. van Tinteren O.S. Hoekstra et al. Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: The PLUS study Eur J Nucl Med Mol Imaging 30 2003 1444-1449